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Abstract
Background: Of patients undergoing surgery, 22 to 57 % have been reported to be using naturopathic medicines.
Several of these medicines have been reported to increase bleeding or enhance the effect of other drugs that
increase bleeding. The Swedish Medical Products Agency recommends cessation of the use of the naturopathic
medicines echinacea, fish oil, ginkgo biloba, ginseng, St. John’s wort, valeriana and garlic 2 weeks before surgery.
The aim of this pilot study was to examine the effects of these 7 naturopathic medicines in healthy humans by
utilising multiple electrode aggregometer (Multiplate) and viscoelastic rotational thromboelastometer (ROTEM) to
obtain data for sample size calculation before a larger trial.
Methods: Thirty-five healthy volunteers ingested one of the listed naturopathic medicines for 7 days. Each naturopathic
medicine was taken in a recommended standard dose by 5 volunteers. ROTEM clot initiation (CT), clot formation (CFT),
α-angle (AA) and clot structure (MCF) were analysed with tissue factor activated (EXTEM) and native (NATEM)
assays. The Multiplate platelet aggregation area under curve (AUC) was measured with adenosine diphosphate
(ADP), collagen (COL) and arachidonic acid (ASPI) assays.
Results: Multiplate with ADP agonist decreased from 73 ± 8.7 AUC to 60 ± 5.9 AUC (P = 0.003, 95 % confidence
interval (CI) −19.2 to −7.6) after medication with fish oil, but fish oil had no effect on COL or ASPI reagents. None
of the other naturopathic medicines had any effect on Multiplate aggregometry. ROTEM NATEM-CFT increased
from 217 ± 32 s to 283 ± 20 (P = 0.009, 95 % CI 26.8 to 107), and NATEM-AA decreased from 52 ± 3.9° to 44 ± 2.3°
(P = 0.009, 95 % CI −12.0 to −3.2) after medication with fish oil. There were no significant changes in the other
NATEM or EXTEM parameters. The other naturopathic medicines had no significant effects on ROTEM or Multiplate
aggregometry.
Conclusions: We have demonstrated that a recommended standard intake of 1260 mg Ω-3 polyunsaturated fatty
acids (fish oil) daily – but not echinacea, ginkgo biloba, ginseng, St. John’s wort, valeriana or garlic – may decrease
platelet aggregation and clot formation. A larger trial in this setting would be meaningful to perform.
Trial registration: Trial registration ISRCTN78027929. Registered 19 May 2015.
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Background
Of patients undergoing surgery, 22 to 57 % have been
reported to be using naturopathic medicines [1, 2]. Al-
though evidence based data of increased perioperative
bleeding are lacking [3] several naturopathic medicines
may increase the risk of bleeding or enhance the effect
of other drugs that may increase bleeding, such as non-
steroid anti-inflammatory drugs [4]. The recommenda-
tion of the Swedish Medical Products Agency [5] is to
stop the usage of the naturopathic medicines echinacea,
fish oil, ginkgo biloba, ginseng, St. John’s wort, valeriana
and garlic 2 weeks before elective surgery to avoid un-
wanted bleeding effects.
The mechanism for increased bleeding may include in-
hibitory effects of these medications on platelet functions
mediated through several different pathophysiological
pathways [6], including adenosine diphosphate- (ADP) [7],
collagen- (COL) [8] and adrenaline-induced inhibition of
platelet aggregation [9]. Furthermore, thromboxane B2
levels [10], platelet P-selectin expression [11], platelet
CD63 expression [12] and arachidonic acid levels of plate-
let phospholipids [13, 14] may also be affected. In the past,
measuring platelet function was a difficult and laborious
process, but it has recently been made more accessible
through different point-of-care (POC) techniques. Throm-
boelastography measures the dynamic interaction between
aggregating platelets and polymerised fibrin and the final
strength of a blood clot in whole blood, whereas routine
plasma-based coagulation tests measure only the time
until clotting begins [15]. There is observational evidence
that 2 POC viscoelastic devices, thromboelastography
(TEG) and rotational thromboelastometer (ROTEM), may
be superior to routine tests in monitoring and guiding
hemostatic resuscitation in bleeding patients [15]. How-
ever these techniques are not proven to reduce mortality
[16] and several concerns have been raised using the
viscoelastic devices bedside by non-laboratory personal
because these tests are hard to standardize [17] and some
authors describe their predictive performance not consist-
ently superior to routine tests [18]. Furthermore, TEG and
ROTEM cannot measure the effects of weak platelet-
inhibiting drugs like acetylsalicylic acid (ASA) nor strong
platelet-inhibiting drugs such as ADP-inhibitors. There-
fore, different POC platelet aggregation tests use different
platelet agonists to monitor the effects of ASA and ADP-
inhibitors. One such test is multiple electrode aggregome-
try (MEA; Multiplate).
Neither ROTEM nor TEG has been used to monitor
naturopathic medicines. Fish oil has been shown to re-
duce platelet collagen receptor function, as detected by
the Multiplate COL [19] and ADP tests [11]. A review
article mentions reduction of thromboxane A2 levels as
a possible mechanism of garlic and fish oil [20]. ASA
also inhibits thromboxane A2, and therefore Multiplate
analysis with an arachidonic acid agonist designed to de-
tect ASA platelet inhibition (Multiplate ASPI test) might
have the potential to detect effects of naturopathic
medicines.
The aim of this pilot study was to examine the effects
in healthy volunteers of 7 days of peroral intake of ech-
inacea, fish oil, ginkgo biloba, ginseng, St. John’s wort,
valeriana and garlic naturopathic medicines (Table 1) on
Multiplate aggregometry and ROTEM and to obtain
data for sample size calculation before a larger trial.
Methods
The study was approved by the Regional Ethical Review
Board, Lund, Sweden (registration number 2010/482).
Thirty-five non-smoking, healthy, Caucasian volunteers
(16 men and 18 women, ages 21 to 62 [median 27 and
mean 36 years old]) gave signed consent to ingest one of
the listed naturopathic medicines for 7 days (Fig. 1). Vol-
unteers were all staff members at the intensive care unit,
University Hospital, Lund, Sweden, and were considered
to have normal laboratory parameters. Exclusion criteria
were pregnancy, planned surgery, or intake of any kind
of anticoagulant or antithrombotic medicine, including re-
cent intake of aspirin or non-steroid anti-inflammatory
drugs. Five volunteers took each naturopathic drug (ech-
inacea, fish oil, ginkgo biloba, ginseng, St. John’s wort,
valeriana and garlic) in a recommended standard dose
(Table 1). No differences in age or sex were found between
the treatment groups.
The test period of 7 days was chosen with the normal
7- to 8-day lifespan of platelets in mind [21]. When
assessing platelet function and coagulation after the test
period, most platelets in circulation would have been ex-
posed to the current medication. Recommended stand-
ard dosing was selected because we wanted to test the
effect of naturopathic medicines in a clinically relevant
and common dose.
Blood sampling
Venous blood was collected using the venipuncture tech-
nique (Vacutainer) before and after 7 days of naturopathic
Table 1 Standard dosages as described on the packages were
used for 7 days
Naturopathic
medicine
Grams of active substance/day
Echinacea 49.6 mg dried root and herb
Fish oil 1260 mg Ω-3 polyunsaturated fatty acids
Ginkgo biloba 200 mg extract (represents 3–4 g dried ginkgo leaf)
Ginseng 200 mg extract (represents 210 mg dried ginseng root)
St John’s wort 120–219 mg extract (represents 0,39–0,87 g dried herb)
Valeriana 400 mg extract (approximately 2,4 g dried root)
Garlic 1260 mg garlic oil macerate (represents 3 mg allicin)
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medication. First, 3 ml of blood was discarded. For the
ROTEM analysis, a 2.7 mL tube containing 0.109 M cit-
rate (3.2 % citrate, BD Vacutainer systems, Plymouth, UK)
was used, and for the Multiplate analysis, blood was
collected in a 3.0 mL Hirudin tube (Dynabyte GmbH,
Munich, Germany).
Viscoelastic coagulation analysis
The viscoelastic coagulation instrument ROTEM
(Pentapharm, Munich, Germany) was chosen to evaluate
if the platelet contribution to secondary haemostasis is
affected after ingestion of the selected naturopathic medi-
cines. Blood was stored at 37 °C according to manufac-
turer instructions, and ROTEM tests were performed
within 120 min after sampling. ROTEM is a viscoelastic
test that measures coagulation in whole blood. Whole
blood (300 μL) is installed in a fixed disposable cuvette
with a rotating pin. When the blood starts to clot, a fibrin
bridge is created between the pin and the cup, and the re-
sistance to rotation is displayed as a graph that indicates
the time for the blood clot to form and the strength of the
clot. For all ROTEM analyses, 20 μL of 0.2 M CaCl2
(StartTem) was added to block the citrate anticoagulant.
Three different ROTEM assays were used. EXTEM and
FIBTEM are tissue factor activated and NATEM is con-
ducted without coagulation activating reagents. The
EXTEM assay is influenced by extrinsic coagulation fac-
tors, platelets and fibrinogen, whereas the FIBTEM assay
provides information regarding the functional fibrinogen
concentration and fibrin stability of the clot.
Parameters for the EXTEM and NATEM assays were
clotting time (CT), clot formation time (CFT), α-angle
(AA) and maximum clot firmness (MCF). CT represents
the time from adding the start reagent until the clot starts
to form. CFT gives information about the initial speed of
the formation of the clot, AA displays the rate at which a
solid clot forms, and MCF indicates the maximal strength
of the clot. Together the parameters provide an overview
of the coagulation process. Only MCF was recorded for
the FIBTEM analyses.
Impedance aggregometry
Platelet aggregation was measured using Multiplate
(Roche Diagnostics Scandinavia AB, Bromma, Sweden).
Tests were performed between 30 min and 2 h after blood
sampling. Multiplate measures platelet aggregation by
impedance aggregometry. The device has 5 channels by
which platelet aggregation after the addition of different
platelet agonists can be simultaneously measured. The test
cells contain 2 independent silver-coated copper wires
between which electricity is conducted. As the platelets
aggregate on the wires, the electrical impedance in the
electrical circuit is increased and presented as a graph
where the area under curve (AUC) quantifies the aggrega-
tion. In this study, 3 different platelet agonists were used:
adenosine diphosphate (ADP) agonist (6.5 μM), collagen
(COL) agonist (3.2 μg/ml) and arachidonic acid (ASPI)
agonist (0.5 mM).
Statistical analysis
All variables were treated as normally distributed and
are presented as mean ± standard deviation (SD). Paired t-
tests were used to test for statistically significant differences
before and after administration of the naturopathic medi-
cines. To reduce the risk of a Type I error due to multiple
testing, the significance level was set at a P-value of <0.01.
All statistical analyses were performed using GraphPad
Prism 6 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Multiplate
Multiplate with ADP agonist decreased from 73 ± 8.7
AUC to 60 ± 5.9 AUC (P = 0.003, 95 % confidence inter-
val (CI) −19.2 to −7.6) after 7 days of fish oil intake
(Fig. 2 and Table 2). COL and ASPI did not show this
effect. None of the other naturopathic medicines had
any significant effects on Multiplate aggregometry.
Fig. 1 Flow chart
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ROTEM
NATEM-CFT increased from 217 ± 32 s to 283 ± 20 s (P =
0.009, 95 % CI 26.8 to 107), and NATEM-AA decreased
from 52 ± 3.9° to 44 ± 2.3° (P = 0.009, 95 % CI −12.0
to −3.2) after 7 days of fish oil intake (Fig. 3 and Table 2).
Fish oil had no effect on the other NATEM or any EXTEM
parameters.
There were no significant ROTEM changes with the
other naturopathic medicines.
Discussion
In this prospective single-centre pilot study, we have
demonstrated that the intake of 1260 mg Ω-3 polyunsat-
urated fatty acids (fish oil) daily was the only one of 7
different naturopathic medications (also including
echinacea, fish oil, ginkgo biloba, ginseng, St. John’s
wort, valeriana and garlic) that showed significant
changes in haemostatic point-of-care analyses. Multiplate
ADP and ROTEM NATEM assays were weakened after 7
consecutive days with recommended peroral dosages of
fish oil. These results suggest that it would be meaningful
to perform a larger study with more healthy volunteers
using ROTEM and Multiplate assays to measure the effect
of some of the naturopathic medications included in this
investigation.
The study was designed to reveal if any of these naturo-
pathic medicines in recommended dosages could produce
measurable effects on Multiplate and ROTEM aggregome-
try for the purposes of sample size calculation prior to a
larger trial. These instruments are frequently used to detect
defects in haemostasis in bleeding patients. Hodges et al.
[2] reported that 22 to 37 % of patients and Adusumilli [1]
reported that up to 57 % of patients undergoing elective
surgery are using naturopathic medicines. The present
study is warranted since use of naturopathic medicines is
increasingly common and their use may be a factor to
consider when treating bleeding patients, who are often
monitored with the haemostatic instrument ROTEM (and
sometimes Multiplate).
Fish oil has been associated with a 7 % lower risk
of coronary heart disease mortality [22]. The exact
mechanisms by which fish oil exerts such a protective
function are still debated. The main mechanisms proposed
include the lowering of plasma triglyceride levels, increased
anti-inflammatory responses, plaque stabilisation and
decreased platelet aggregation [23]. Furthermore, fish
oil has been shown to reduce ADP-, adrenaline- and
COL-induced platelet aggregation as well as P-selectin
expression and to increase bleeding time [20]. Veljovic
et al. [19] studied intravenous administration of 2100 mg
Ω-3 polyunsaturated fatty acids 1 day and 4 h prior to
coronary bypass surgery in a prospective randomized con-
trolled trial. Compared to controls, Ω-3 polyunsaturated
fatty acids significantly reduced postoperative platelet
aggregation measured with Multiplate COL assay. Our
results are therefore consistent with previous labora-
tory findings showing that fish oil reduces platelet
aggregation and weakens coagulation. Even though
fish oil has shown clear signs of decreasing platelet
Fig. 2 Results from Multiplate analysis of whole blood before
and after 7 days of fish oil medication. Before and after results
are compared using paired t-test. **P < 0.01. n.s. = non-significant
Table 2 Results from Multiplate and ROTEM, fish oil
Before After P 95 % CI
Multiplate
ADP (AUC) 73 ± 8.7 60 ± 5.9 0.003 −19.2 to −7.6
COL (AUC) 67 ± 6.7 64 ± 6.8 0.50 −15.2 to 8.8
ASPI(AUC) 77 ± 7.9 76 ± 11.8 0.86 −12.6 to 11.0
ROTEM
EXTEM-CT (sec) 56 ± 10 61 ± 36 0.79 −48.4 to 59.2
EXTEM-CFT (sec) 103 ± 36 110 ± 31 0.81 −67.5 to 81.0
EXTEM-AA (degrees) 70 ± 6.5 68 ± 5.6 0.76 −15.1 to 11.9
EXTEM-MCF (mm) 62 ± 3.6 58 ± 4.3 0.23 −11.9 to 3.9
NATEM-CT (sec) 670 ± 68 728 ± 64 0.38 −102 to 216
NATEM-CFT (sec) 217 ± 32 284 ± 17 0.009 26.8 to 107
NATEM-AA (degrees) 52 ± 3.9 44 ± 2.3 0.009 −12.0 to −3.2
NATEM-MCF (mm) 51.7 ± 5.8 46.8 ± 3.9 0.18 −12.9 to 3.3
Results from Multiplate and ROTEM before and after peroral intake of 1260 mg
Ω-3 polyunsaturated fatty acids (fish oil) for 7 days, mean ± SD. CI confidence
interval. ADP adenosine diphosphate (6.5 μM). AUC area under curve. COL col-
lagen (3.2 μg/ml). ASPI arachidonic acid (0.5 mM). EXTEM tissue factor triggered
viscohemostatic test. CT clotting time. CFT clot formation time. AA α-angle. MCF
maximal clot firmness. NATEM viscohemostatic test without coagulation
activating reagents
Bagge et al. BMC Complementary and Alternative Medicine  (2016) 16:64 Page 4 of 8
function and coagulation ability, the link to actual
bleeding risk of these laboratory findings remains un-
certain. Watson et al. [24] retrospectively reviewed
the medical records of bleeding complications in pa-
tients treated with high-dose fish oil, clopidogrel and
ASA compared with only clopidogrel and ASA and
found no difference in bleeding incidence between
the groups. In a recent review, Wachira et al. [25] de-
scribed other protective mechanisms of fish oil even
more important than platelet aggregation reduction
and found no reason to stop fish oil intake before in-
vasive procedures.
Point-of-care devices such as ROTEM and Multiplate
have gained popularity during the last decade and are
widely used in perioperative settings and in cardiology
to monitor platelet-inhibiting drugs. Studies suggest that
ROTEM is useful in guiding transfusion therapy [26]
and diagnosing bleeding complications [27]. However
both instruments have limitations and do not provide a
complete picture of plasma coagulation and platelet
Fig. 3 Results from ROTEM analysis of whole blood before and after 7 days of fish oil medication. Before and after results are compared using
paired t-test. ** = P < 0.01. n.s. = non-significant
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function [28]. In the ROTEM instrument, coagulation
is activated by direct addition of an activator, thus
bypassing primary haemostasis and preventing detec-
tion of disorders of primary haemostasis as well as the
presence of potent platelet inhibitory drugs. The Multi-
plate instrument detects defect pathways in platelets
activated with specific agonists but may fail to identify
other disorders, and it is also dependent on the number
of platelets [29–31].
In the present study we showed decreased platelet ag-
gregation and clot formation with Multiplate ADP and
ROTEM NATEM assays after intake of fish oil. How-
ever, there were no significant effects on ROTEM or
Multiplate aggregometry after ingestion of the other
tested naturopathic medicines (garlic, ginseng, ginkgo
biloba, echinacea, St. John’s wort and valeriana). These
medicines have previously been shown to weaken coagu-
lation and platelet function in other studies. Sirvastava
et al. [32] performed an in vitro experiment in which an
aqueous garlic extract was added to whole blood and
found a dose-dependent inhibition of platelet aggregation
with several different agonists using light transmission
aggregometry. Chang et al. [33] added garlic extracts to
blood from healthy volunteers and showed weakened
platelet aggregation after adding collagen agonists in very
low to very high concentrations. Kiesewetter et al. [34]
also demonstrated reduced platelet aggregation in volun-
teers with cerebrovascular risk factors after daily intake of
800 mg of powdered garlic using a turbidometric platelet
aggregation method. However, Scharbert et al. [35], using
PFA-100 (agonists epinephrine, and collagen) and Multi-
plate (agonists arachidonic acid and collagen), failed to
detect any platelet effects with very-low-dose dietary garlic
in healthy volunteers. These results demonstrate, in con-
trast to our study, that high-dose garlic may decrease
platelet aggregation. However, in many of these studies
garlic extracts were added in vitro, which may not repre-
sent what happens in vivo, and one study [35] used very
low doses of garlic. These circumstances may partly ex-
plain the different results in the previous studies and the
present study.
Regarding the other naturopathic medications studied,
ginseng has been proven to inhibit platelet activation
[36]. In a study by Zhou et al., flow cytometry, Born
aggregometry and Western blot were used to show that
platelet function was inhibited via the mitogen-activated
protein kinase pathway. Ginkgo biloba has been demon-
strated to potentiate the ticlopidine inhibitory effect on
ADP receptors in stroke patients [37]. In the periopera-
tive setting, echinacea has been reported to be safe [38].
St. John’s wort exerts its effects by inhibiting serotonin,
norepinephrine and dopamine reuptake by neurons. Like
other serotonin reuptake inhibitors, it has the potential
to depress platelet function. However, a direct effect on
platelet function or coagulation has so far not been doc-
umented with St. John’s wort [4]. Valeriana is extensively
used in Europe, is not always recommended to be dis-
continued before surgery, and has so far no documented
increased bleeding risk [2, 4].
We were unable to demonstrate changes in platelet ag-
gregation and coagulation after ingestion of naturopathic
medicines other than fish oil. This suggests that Multi-
plate tests and ROTEM assays are not sensitive enough
to assess the effects on the human coagulation system
and platelets after medication with garlic, ginseng,
ginkgo biloba, echinacea, St. John’s wort or valeriana,
and that we need to consider using a more sensitive and
specific method. It will probably be difficult to find a
single method that can measure the effects on platelet
function and coagulation of all the different medicines.
Instead, we have to consider customizing methods by
taking into account the mechanisms of each medicine.
There are few prospective studies on the impact of herb
use on bleeding complications and surgical outcomes.
Shalansky et al. [39] prospectively studied patient-assessed
bleeding complications in patients using complementary
and alternative medicine who were also treated with war-
farin, and they found increased bleeding with coenzyme
Q10 (odds ratio [OR] 3.69, 95 % CI 1.88 to 7.24) and gin-
ger (OR 3.20, 95 % CI 2.42 to 4.24). Several cases of spon-
taneous intracranial bleeding, one case of spontaneous
hyphema and one case of postoperative bleeding following
laparoscopic cholecystectomy have been attributed to
ginkgo use [4]. Ginsenosides inhibit platelet aggregation
irreversibly, prolonging both the coagulation time of
thrombin and activated partial thromboplastin. Lee et al.
[40] demonstrated an increased risk of perioperative
events for patients using 1 or more of 45 different trad-
itional Chinese herbal medicines compared to patients not
using these medicines. In contrast, Kepler et al. [41] found
no increase in bleeding in patients using fish oil supple-
ments prior to spinal decompression surgery. The study
by Kepler et al. was well powered, making the negative
result significant, but it is in disagreement with previous
experimental studies demonstrating impaired platelet and
coagulation function after fish oil ingestion. Further clin-
ical studies are needed before any firm conclusions can be
drawn. In anticipation of more such studies, experts have
recommended avoiding herbs for at least 2 weeks prior to
surgery [3]. This is a reasonable recommendation because
stopping the naturopathic medications during this limited
time is probably not harmful and may decrease the risk of
perioperative complications.
We recognise the limitations of this study. The present
study was a pilot study with low power and with the
main aim of obtaining data that can provide a basis for
sample size calculation before a larger trial. This means
that even though we could not detect an effect on
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ROTEM and Multiplate assays of 6 out of 7 naturo-
pathic medicines (echinacea, ginkgo biloba, ginseng, St.
John’s wort, valeriana and garlic), there may still be
bleeding risks related to these medicines, as shown by
many others [5–9, 11, 12, 20] and also that the signifi-
cant results must be interpreted with caution [42]. Fur-
thermore, this study did not include platelet aggregation
tests with agonists in different concentrations. This
means that the question of whether naturopathic medi-
cations are able to inhibit platelet function at lower
concentrations of agonists was not tested.
Conclusion
We have demonstrated that the recommended peroral
intake of 1260 mg Ω-3 polyunsaturated fatty acids (fish
oil) daily was the only one of 7 different naturopathic
medications (also including echinacea, fish oil, ginkgo
biloba, ginseng, St. John’s wort, valeriana and garlic) that
had a significant effect on Multiplate platelet aggregation
and ROTEM viscoelastic clot formation. Fish oil caused
decreased platelet aggregation after stimulation with
standard-concentration ADP agonist (6.5 μM) in the
Multiplate instrument and a prolonged clot formation
time in the NATEM assay in the ROTEM instrument.
These results must be interpreted with some caution
due to low statistical power and should be confirmed in
larger trials.
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